Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
Last trade$0.304
Day change-$0.0181 (-5.62%)
Day range$0.295 – $0.36
Volume203,841
Market cap$11M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for QNME.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for QNME.
Recent news
Company coverage with links to the original publishers.
Quanome Technologies (Nasdaq: QNME) announced an approximately $18.8 million purchase agreement for NVIDIA GPU computing infrastructure to build its AI cloud business through subsidiary XDT Infrastructure I, LLC. The company aims to provide managed access to AI computing capacity for businesses, with its first U.S. AI infrastructure hub expected to be operational in Q4 2026. This move aligns with growing AI adoption among U.S. businesses and supports Quanome's broader quantum and AI systems strategy.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.